Genprex Inc reports results for the quarter ended in December - Earnings Summary

Genprex

02/04/2024 18:37

* Genprex Inc  GNPX.OQ  reported a quarterly adjusted loss
of
$3.96​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of
$-6.00.  The mean expectation of three analysts for the quarter
was for a loss of $3.93 per share. Wall Street expected
results to range from $-5.60 to -80 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Genprex Inc's reported EPS for the quarter was a loss of
$3.96​.
    * The company reported a quarterly loss of $5.93 million.
    * Genprex Inc shares had fallen by 0.3% this quarter and
lost 67.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 391.2% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Genprex Inc is
$165.00 
This summary was machine generated from LSEG data April 2 at
05:37 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -3.93          -3.96          Missed
 Sep. 30 2023      -4.40          -5.20          Missed
 Jun. 30 2023      -4.80          -6.00          Missed
 Mar. 31 2023      -4.80          -7.60          Missed